BioCentury
ARTICLE | Clinical News

Celsentri maraviroc regulatory update

June 25, 2007 7:00 AM UTC

PFE received an approvable letter from FDA for Celsentri maraviroc for use in combination with other antiretroviral agents for treatment-experienced adult patients infected with CC chemokine receptor...